
How COBENFY™ works
(xanomeline and trospium chloride)
Actor portrayals.
COBENFY is not an antipsychotic. It works differently
See how COBENFY works to treat schizophrenia

COBENFY is the first and only FDA-approved schizophrenia medicine that is thought to work by activating small proteins in the brain called muscarinic acetylcholine receptors.
COBENFY is a different approach to schizophrenia treatment. COBENFY is a unique combination of 2 medicines: xanomeline and trospium chloride.
Xanomeline (Za-NO-muh-leen) is thought to activate muscarinic receptors in your brain to help adjust important chemical messengers related to your schizophrenia symptoms.
+
Trospium (TRO-spee-um) chloride may help prevent xanomeline from working outside your brain so that other parts of your body are less likely to be impacted.
The exact way COBENFY works is not fully understood.
Education is very important. Taking an active role in your journey is the way to go.
- |
Chayilee lives with schizophrenia, is paid by BMS, and not on COBENFY. |
Kelsey is paid by BMS and not on COBENFY.